Procedure-to-delivery interval after late amniocentesis and the need for routine antenatal corticosteroids

References

• Shalev J, Meizner I, Rabinerson D, et al. Elective cytogenetic amniocentesis in the third trimester for pregnancies with high risk factors. Prenat Diagn. 1999;19(8):749–752.
   PubMed Web of Science ®Google Scholar
• Gabbay R, Yogev Y, Melamed N. Pregnancy outcome after third trimester amniocentesis: a single center experience. J Matern Fetal Neonatal Med. 2012;25(6):666–668.
   PubMed Web of Science ®Google Scholar
• Seeds JW. Diagnostic mid trimester amniocentesis: how safe? Am J Obstet Gynecol. 2004;191(2):607–615.
   PubMed Web of Science ®Google Scholar
• Tabor A, Vestergaard CH, Lidegaard Ø. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol. 2009;34(1):19–24.
   PubMed Web of Science ®Google Scholar
• O'Donoghue K, Giorgi L, Pontello V, et al. Amniocentesis in the third trimester of pregnancy. Prenat Diagn. 2007;27(11):1000–1004.
   PubMed Web of Science ®Google Scholar
• Stark CM, Smith RS, Lagrandeur RM, et al. Need for urgent delivery after third-trimester amniocentesis. Obstet Gynecol. 2000;95(1):48–50.
   PubMed Web of Science ®Google Scholar
• Salomon LJ, Sotiriadis A, Wulff CB, et al. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol. 2019;54(4):442–451.
   PubMed Web of Science ®Google Scholar
• Beta J, Zhang W, Geris S, et al. Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis. Ultrasound Obstet Gynecol. 2019;54(4):452–457.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Beta J, Picciarelli G, et al. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45(1):16–26.
   PubMed Web of Science ®Google Scholar
• Daum H, Ben David A, Nadjari M, et al. Role of late amniocentesis in the era of modern genomic technologies. Ultrasound Obstet Gynecol. 2019;53(5):676–685.
   PubMed Web of Science ®Google Scholar
• Geffen KT, Ben-Zvi O, Weitzner O, et al. The yield and complications of amniocentesis performed after 24 weeks of gestation. Arch Gynecol Obstet. 2017;296(1):69–75.
   PubMed Web of Science ®Google Scholar
• Picone O, Senat MV, Rosenblatt J, et al. Fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis? Fetal Diagn Ther. 2008;23(1):30–35.
   PubMed Web of Science ®Google Scholar
• Hodor JG, Poggi SH, Spong CY, et al. Risk of third-trimester amniocentesis: a case-control study. Am J Perinatol. 2006;23(3):177–180.
   PubMed Web of Science ®Google Scholar
• Practice ACoO. ACOG Committee Opinion No. 475: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2011;117(2 Pt 1):422–424.
   PubMedGoogle Scholar
• Practice ACoOaGCoO, Medicine SfMF. Committee Opinion No.677: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2016;128(4):e187–e194.
   Google Scholar
• Osterman MJ, Kochanek KD, MacDorman MF, et al. Annual summary of vital statistics: 2012–2013. Pediatrics. 2015;135(6):1115–1125.
   PubMed Web of Science ®Google Scholar
• Hallman M. The story of antenatal steroid therapy before preterm birth. Neonatology. 2015;107(4):352–357.
   PubMed Web of Science ®Google Scholar
• Gynecologists ACoOa, Bulletins—Obstetrics CoP. ACOG practice bulletin no. 127: management of preterm labor. Obstet Gynecol. 2012;119(6):1308–1317.
   PubMedGoogle Scholar
• Miracle X, Di Renzo GC, Stark A, et al. Guideline for the use of antenatal corticosteroids for fetal maturation. J Perinat Med. 2008;36(3):191–196.
   PubMed Web of Science ®Google Scholar
• Msan AK, Usta IM, Mirza FG, et al. Use of antenatal corticosteroids in the management of preterm delivery. Am J Perinatol. 2015;32(5):417–426.
   PubMed Web of Science ®Google Scholar
• Sotiriadis A, Tsiami A, Papatheodorou S, et al. Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(6):1385–1396.
   PubMed Web of Science ®Google Scholar
• Sifianou P, Thanou V, Karga H. Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation. J Pediatr Pharmacol Ther. 2015;20(2):138–143.
   PubMedGoogle Scholar
• Kuo AH, Li J, Li C, et al. Prenatal steroid administration leads to adult pericardial and hepatic steatosis in male baboons. Int J Obes (Lond). 2017;41(8):1299–1302.
   PubMed Web of Science ®Google Scholar
• Iliodromiti S, Mackay DF, Smith GC, et al. Apgar score and the risk of cause-specific infant mortality: a population-based cohort study. Lancet. 2014;384(9956):1749–1755.
   PubMed Web of Science ®Google Scholar
• de Barros JWF, Borges CDS, Missassi G, et al. Impact of intrauterine exposure to betamethasone on the testes and epididymides of prepubertal rats. Chem Biol Interact. 2018;291:202–211.
   PubMed Web of Science ®Google Scholar
• Schmitz T. Prevention of preterm birth complications by antenatal corticosteroid administration. J Gynecol Obstet Biol Reprod (Paris). 2016;45(10):1399–1417.
   PubMedGoogle Scholar
• Saugstad OD, Kwinta P, Wollen EJ, et al. Impact of antenatal glucocorticosteroids on whole-genome expression in preterm babies. Acta Paediatr. 2013;102(4):349–355.
   PubMed Web of Science ®Google Scholar
• Tseng WN, Chen CC, Yu HR, et al. Antenatal dexamethasone exposure in preterm infants is associated with allergic diseases and the mental development index in children. Int J Environ Res Public Health. 2016;13(12):1206.
   Web of Science ®Google Scholar
• Practice CoO. Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130(2):e102–e109.
   PubMed Web of Science ®Google Scholar